Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼

Friday, January 15, 2010

Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporo

Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women

1 comment:

Your comments?

Note: Only a member of this blog may post a comment.